Oversight and access
Laboratory-developed tests: the category most consumer diagnostics live in
A large share of the tests sold direct to consumers were never individually reviewed by a regulator. Understanding why explains a lot about the market.
When people ask whether a consumer test is approved, the honest answer is usually that the question does not quite apply. Many of these assays sit in a category with a different history and a different set of rules.
The short version
- A laboratory-developed test is designed, made and used within a single laboratory rather than sold as a kit.
- The category grew out of hospital laboratories building assays that no manufacturer supplied.
- Laboratory operations are subject to quality and personnel standards; that is not the same as review of each individual test's clinical validity.
- Oversight of the category has been contested and repeatedly revised, so the current position is worth checking rather than assuming.
Where the category came from
Hospital laboratories have always built their own assays for situations no commercial kit covered: rare conditions, unusual sample types, newly described markers. Requiring individual pre-market review of every such assay would have made much of clinical pathology impossible.
So a distinction developed between a test kit manufactured and sold to other laboratories, which faces device review, and a test developed and performed within one laboratory, which historically did not. That distinction was built for a world of hospital pathology departments.
What it means in a consumer market
The consumer testing industry runs largely on this second model. A company operates or contracts a laboratory, develops its own assay and its own interpretive algorithm, and sells the result. The laboratory itself is subject to quality standards covering personnel, proficiency testing, and procedures.
Those standards address whether the laboratory can produce a reliable, reproducible measurement. They do not establish that the thing being measured predicts anything useful, which is the question a buyer usually has in mind.
That gap between analytical validity, meaning the measurement is accurate, and clinical validity, meaning the result predicts an outcome, is the single most useful distinction in this whole area.
Why the rules keep moving
Regulators have repeatedly proposed extending oversight to this category, and those proposals have been contested by laboratory and hospital bodies concerned about cost and access, and litigated. The result is a position that has changed more than once and may have changed again since this piece was written.
The practical consequence for a reader is that the presence or absence of regulatory review is not a reliable proxy for whether a test is worth taking. The questions that hold up better are who validated it, against what reference standard, and in which population.
Common questions
Is a laboratory-developed test lower quality?
Not inherently. Many are excellent and some of the best assays in clinical use started this way. The point is that individual regulatory review of clinical validity may not have happened.
How do I check a laboratory's credentials?
Look for accreditation and for named oversight of the laboratory. A provider that will not tell you which laboratory runs your sample has answered a different question than the one you asked.
Sources
- Epigenetic clocks: advancing biological age measures towards clinical use — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12905613/
- Biological age testing guidance — https://ubiehealth.com/doctors-note/biological-age-testing-epigenetic-clock-guidance4262q2